Inter-strain differences in glucocorticoid and mineralocorticoid effects on macrophage and lymphocyte functions in mice

Journal of Neuroimmunology

Volumn 204, Issue 1-2, 2008, Pages 38-42

  Harizi, H ^a   Mormede P ^a   Corcuff, J B ^a  

^a NutriNeuro Bordeaux University   (France)

Author keywords

Corticosteroid sensitivity; Corticosteroids; Glucocorticoid receptors; Immune cells; Mice strains; Mineralocorticoid receptors

Indexed keywords

ALDOSTERONE; CONCANAVALIN A; CYCLOOXYGENASE 2; DEXAMETHASONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ALDOSTERONE; ANIMALS; CELL PROLIFERATION; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED STRAINS; MINERALOCORTICOIDS; NITRIC OXIDE SYNTHASE TYPE II; SPECIES SPECIFICITY;

EID: 54349090027     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.08.004     Document Type: Article

References (33)

1. Boyman O., Purton J.F., Surh C.D., and Sprent J. Cytokines and T-cell homeostasis. Curr. Opin. Immunol. 19 (2007) 320-326
2. Calle C., Campion J., Garcia-Arencibia M., Maestro B., and Davila N. Transcriptional inhibition of the human insulin receptor gene by aldosterone. J. Steroid Biochem. Mol. Biol. 84 (2003) 543-553
3. Chun T.Y., Bloem L.J., and Pratt J.H. Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes. Endocrinology 144 (2003) 1712-1717
4. Corbould A. Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women. Horm. Metab. Res. 39 (2007) 915-918
5. Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannum C.H., and Thompson R.C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343 (1990) 341-346
6. Elenkov I.J., and Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 966 (2002) 290-303
7. Elenkov I.J., Webster E.L., Torpy D.J., and Chrousos G.P. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann. N.Y. Acad. Sci. 876 (1999) 1-11 discussion 11-13
8. Fuller P.J., Lim-Tio S.S., and Brennan F.E. Specificity in mineralocorticoid versus glucocorticoid action. Kidney Int. 57 (2000) 1256-1264
9. Grossmann C., Krug A.W., Freudinger R., Mildenberger S., Voelker K., and Gekle M. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1790-1800
10. Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heimdal P.L., Armes L.G., Sommer A., Eisenberg S.P., and Thompson R.C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343 (1990) 336-340
11. Harizi H., and Gualde N. Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 459-466
12. Harizi H., Juzan M., Pitard V., Moreau J.F., and Gualde N. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168 (2002) 2255-2263
13. Harizi H., Homo-Delarche F., Amrani A., Coulaud J., and Mormede P. Marked genetic differences in the regulation of blood glucose under immune and restraint stress in mice reveals a wide range of corticosensitivity. J. Neuroimmunol. 189 1-2 (2007) 59-68
14. Herold M.J., McPherson K.G., and Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63 (2006) 60-72
15. Holtkamp G.M., de Vos A.F., Kijlstra A., and Peek R. Expression of multiple forms of IL-1 receptor antagonist (IL-1ra) by human retinal pigment epithelial cells: identification of a new IL-1ra exon. Eur. J. Immunol. 29 (1999) 215-224
16. Jenkins J.K., and Arend W.P. Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokine 5 (1993) 407-415
17. Joffe H.V., and Adler G.K. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail. Rev. 10 (2005) 31-37
18. Joyce D.A., Steer J.H., and Abraham L.J. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 46 (1997) 447-451
19. Krammer P.H., Arnold R., and Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 7 (2007) 532-542
20. Lam E.Y., Funder J.W., Nikolic-Paterson D.J., Fuller P.J., and Young M.J. Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats. Endocrinology 147 (2006) 3623-3629
21. Lee R.W., Creed T.J., Schewitz L.P., Newcomb P.V., Nicholson L.B., Dick A.D., and Dayan C.M. CD4 + CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids. J. Immunol. 179 (2007) 7941-7948
22. Liberman A.C., Druker J., Perone M.J., and Arzt E. Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev. 18 (2007) 45-56
23. Medzhitov R., and Janeway Jr. C.A. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9 (1997) 4-9
24. Miller A.H., Spencer R.L., Husain A., Rhee R., McEwen B.S., and Stein M. Differential expression of type I adrenal steroid receptors in immune tissues is associated with tissue-specific regulation of type II receptors by aldosterone. Endocrinology 133 (1993) 2133-2140
25. Mormede P., Courvoisier H., Ramos A., Marissal-Arvy N., Ousova O., Desautes C., Duclos M., Chaouloff F., and Moisan M.P. Molecular genetic approaches to investigate individual variations in behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 27 (2002) 563-583
26. Poutsiaka D.D., Clark B.D., Vannier E., and Dinarello C.A. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 78 (1991) 1275-1281
27. Rebsamen M.C., Perrier E., Gerber-Wicht C., Benitah J.P., and Lang U. Direct and indirect effects of aldosterone on cyclooxygenase-2 and interleukin-6 expression in rat cardiac cells in culture and after myocardial infarction. Endocrinology 145 (2004) 3135-3142
28. Sauer J., Castren M., Hopfner U., Holsboer F., Stalla G.K., and Arzt E. Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 81 (1996) 73-79
29. Savoia C., Touyz R.M., Amiri F., and Schiffrin E.L. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 51 (2008) 432-439
30. Sharif O., Bolshakov V.N., Raines S., Newham P., and Perkins N.D. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. 8 (2007) 1
31. Staples K.J., Bergmann M.W., Barnes P.J., and Newton R. Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone. Immunology 109 (2003) 527-535
32. Tumes D.J., Cormie J., Calvert M.G., Stewart K., Nassenstein C., Braun A., Foster P.S., and Dent L.A. Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lung-derived eosinophils. J. Leukoc. Biol. 81 (2007) 1362-1373
33. Young M.J. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr. Opin. Nephrol. Hypertens. 17 (2008) 174-180